Oral selegiline (Eldepryl) is a monoamine oxidase inhibitor used for Parkinson’s disease. At lower oral exposure it preferentially inhibits MAO-B, reducing dopamine breakdown. This selectivity diminishes as exposure increases.


Mechanism and mnemonic
“Elderly Seal’s gills” connects Eldepryl with selegiline. The Mao Zedong cue recalls MAO inhibition. The pegged decagon ballicule maps its pharmacology.
The interaction avatar illustrates CYP2B6 substrate metabolism. Amphetamine-related metabolites can contribute to insomnia.

Formulation and interaction cautions
Higher exposure reduces MAO-B selectivity and increases tyramine-related risk. Serotonergic combinations can cause serotonin toxicity. Medication changes require attention to drug-specific washout intervals.
Go to selegiline transdermal on ballicules.com for the patch formulation used for depression.
